EBV p18 M Recombinant Protein (RPPB5621)
- SKU:
- RPPB5621
- Product type:
- Recombinant Protein
- Size:
- 0.5mg
- Species:
- EBV
- Target:
- p18 M
- Source:
- Escherichia Coli
Description
| Product Name: | EBV p18 M Recombinant Protein |
| Product Code: | RPPB5621 |
| Size: | 0.5mg |
| Species: | EBV |
| Target: | p18 M |
| Source: | Escherichia Coli |
| Formulation: | 50mM Tris-Hcl pH 8.0, 60mM NaCl, 10mM glutathione and 50% glycerol. |
| Stability: | EBV p18 M although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles. |
| Purity: | EBV-p18 protein is >95% pure as determined by 10% PAGE (coomassie staining). |
The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family(which includes Herpes simplex virusand Cytomegalovirus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions. A very limited, distinct set of viral proteins are produced during latent cycle infection. These include Epstein-Barr nuclear antigen(EBNA)-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C, EBNA-leader protein (EBNA-LP) and latent membrane proteins(LMP)-1, LMP-2A and LMP-2B and the Epstein-Barr encoded RNAs(EBERs).
The E.Coli derived recombinant artificial mosaic protein contains two epitopes from C-end associated in one molecule from the HHV-4 p18 regions.
Related Products
